Summary: “The aim of my role is to help as we shift from an organization that was focused on development of MDMA-assisted therapy to one focused on commercialization and licensure approval of that therapy.” — Michael Mullette, Chief Operating Officer (COO) of MAPS Public Benefit Corporation (MAPS PBC)